SNN Network: Nascent Biotech on Developing COVID-19 Therapy and Vaccine Collaboration with Manhattan BioSolutions

Posted May 28, 2020

Nascent Biotech CEO Sean Carrick appears on SNN Network to discuss the company developing COVID-19 therapy and vaccine collaboration with Manhattan BioSolutions.

Recent Posts

VIDEO: Nascent Biotech CEO Sean Carrick at the Emerging Grown Conference
Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued